| Group 1 | Group 2 | Group 3 | P value | |
---|---|---|---|---|---|
 |  |  |  | Group 1 vs. 2 | Group 1 vs. 3 |
Age(years)* | 21.55+/-4.74 | 29.7+/-9.16 | 18.7+/-4.45 | 0.001 | 0.057 |
Sex (M/F) | 10/10 | 13/7 | 10/10 | 0.33 | 1 |
Modified Stage ‡ | 3 (1–6) | 2 (0–6) | 2 (1–4) | 0.02 | 0.01 |
Modified HAI grade ‡ | 5 (1–8) | 6 (2–11) | 2 (0–6) | 0.36 | 0.001 |
   Periportal inflammation‡ | 1.5 (0–3) | 2 (0–4) | 0 (0–2) | 0.77 | 0.004 |
   Confluent Necrosis‡ | 0 (0–1) | 0 (0–2) | 0 (0–1) | 0.13 | 0.091 |
   Focal Necrosis‡ | 1 (0–2) | 2 (1–2) | 1 (0–2) | 0.10 | 0.45 |
   Portal Inflammation‡ | 2 (0–3) | 2 (1–4) | 1 (0–2) | 0.87 | 0.002 |
Iron Score ‡ | 3 (2–4) | 0 (0–1) | 4 (2–4) | 0.000 | 0.024 |
Steatosis (%) | 10 | 20 | 0 | 0.66 | 0.48 |